Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 192 participants.

Also called NCT01070069

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 192 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as a collaborator
  • Endologix Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01070069
Other papers using this trial's data
  • A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial) Journal of vascular surgery, 2014-05 DOI, PubMed 24440678

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01070069. Randomized; no masking; primary purpose treatment. Start 2010-04-13 (actual); primary completion 2012-03-09 (actual). Results posted on 2022-06-07.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
Acronym
PEVAR
Condition
Abdominal Aortic Aneurysm
Intervention (Device)
PEVAR (ProGlide closure)
Intervention (Device)
SEVAR (IntuiTrak)
Intervention (Device)
PEVAR (Prostar XL closure)
Lead sponsor
Endologix (class: industry)
Collaborator
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01070069
Content hash
33542da9e9e91dc185b0a87658db700b8c142f3213665b6a4eae07ccf9cfcbfc